Book contents
- Frontmatter
- Contents
- Editorial board
- Acknowledgements
- List of contributors
- Introduction
- Part I
- Part II
- 25 Ethical principles for medical research involving human subjects
- 26 The Belmont Report: ethical principles and guidelines for the protection of human subjects of research
- 27 ICH Good Clinical Practice Guideline
- 28 Governance arrangements for NHS research ethics committees
- 29 The research governance framework for health and social care
- 30 EU Clinical Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations, and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
- 31 European Convention on human rights and biomedicine (ETS 164) and additional protocol on the prohibition of cloning human beings
- 32 Good research practice
- 33 Research: the role and responsibilities of doctors
- 34 Guidelines for company-sponsored safety assessment of marketed medicines (SAMM)
- 35 Guidelines for medical experiments in non-patient human volunteers
- 36 Facilities for non-patient volunteer studies
- 37 Multi-centre research in the NHS – the process of ethical review when there is no local researcher
- 38 Medical devices regulations and research ethics committees
- 39 NHS indemnity – arrangements for clinical negligence claims in the NHS
- 40 Clinical trial compensation guidelines
- 41 Research ethics: guidance for nurses involved in research or any investigative project involving human subjects
- 42 Ethical principles for conducting research with human participants
- 43 Statement of ethical practice
- 44 Human tissue and biological samples for use in research
- 45 Transitional guidelines to facilitate changes in procedures for handling ‘surplus’ and archival material from human biological samples
- 46 Code of practice on the use of fetuses and fetal material in research and treatment (extracts from the Polkinghorne Report)
- 47 Guidance on the supply of fetal tissue for research, diagnosis and therapy
- 48 Guidance on making proposals to conduct gene therapy research on human subjects (seventh annual report – section 1)
- 49 Report on the potential use of gene therapy in utero
- 50 Human fertilisation and embryology authority – code of practice (extracts)
- 51 Guidelines for researchers – patient information sheet and consent form
- 52 ABPI Guidance note – patient information and consents for clinical trials
- 53 The protection and use of patient information (HSG(96)18/LASSL(96)5)
- 54 The Caldicott Report on the review of patient-identifiable information – executive summary December 1997
- 55 Personal information in medical research
- 56 Use and disclosure of medical data – guidance on the Application of the Data Protection Act, 1998, May 2002
- 57 Guidelines for the ethical conduct of medical research involving children
- 58 Clinical investigation of medicinal products in the paediatric population
- 59 Guidelines for researchers and for ethics committees on psychiatric research involving human participants – executive summary
- 60 The ethical conduct of research on the mentally incapacitated
- 61 Volunteering for research into dementia Alzheimer's Society
- 62 Knowledge to care: research and development in hospice and specialist palliative care – executive summary
- 63 NUS guidelines for student participation in medical experiments and guidance for students considering participation in medical drug trials
- 64 Ethical considerations in HIV preventive vaccine research
- 65 2002 international ethical guidelines for biomedical research involving human subjects
- 66 1991 international guidelines for ethical review of epidemiological studies
- 67 Operational guidelines for ethics committees that review biomedical research
- 68 Registration of an institutional review board (IRB) or independent ethics committee (IEC)
- 69 International guidelines on bioethics (informal listing of selected international codes, declarations, guidelines etc. on medical ethics/bioethics/health care ethics/human rights aspects of health)
- Index
58 - Clinical investigation of medicinal products in the paediatric population
Published online by Cambridge University Press: 08 January 2010
Edited by
Book contents
- Frontmatter
- Contents
- Editorial board
- Acknowledgements
- List of contributors
- Introduction
- Part I
- Part II
- 25 Ethical principles for medical research involving human subjects
- 26 The Belmont Report: ethical principles and guidelines for the protection of human subjects of research
- 27 ICH Good Clinical Practice Guideline
- 28 Governance arrangements for NHS research ethics committees
- 29 The research governance framework for health and social care
- 30 EU Clinical Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations, and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
- 31 European Convention on human rights and biomedicine (ETS 164) and additional protocol on the prohibition of cloning human beings
- 32 Good research practice
- 33 Research: the role and responsibilities of doctors
- 34 Guidelines for company-sponsored safety assessment of marketed medicines (SAMM)
- 35 Guidelines for medical experiments in non-patient human volunteers
- 36 Facilities for non-patient volunteer studies
- 37 Multi-centre research in the NHS – the process of ethical review when there is no local researcher
- 38 Medical devices regulations and research ethics committees
- 39 NHS indemnity – arrangements for clinical negligence claims in the NHS
- 40 Clinical trial compensation guidelines
- 41 Research ethics: guidance for nurses involved in research or any investigative project involving human subjects
- 42 Ethical principles for conducting research with human participants
- 43 Statement of ethical practice
- 44 Human tissue and biological samples for use in research
- 45 Transitional guidelines to facilitate changes in procedures for handling ‘surplus’ and archival material from human biological samples
- 46 Code of practice on the use of fetuses and fetal material in research and treatment (extracts from the Polkinghorne Report)
- 47 Guidance on the supply of fetal tissue for research, diagnosis and therapy
- 48 Guidance on making proposals to conduct gene therapy research on human subjects (seventh annual report – section 1)
- 49 Report on the potential use of gene therapy in utero
- 50 Human fertilisation and embryology authority – code of practice (extracts)
- 51 Guidelines for researchers – patient information sheet and consent form
- 52 ABPI Guidance note – patient information and consents for clinical trials
- 53 The protection and use of patient information (HSG(96)18/LASSL(96)5)
- 54 The Caldicott Report on the review of patient-identifiable information – executive summary December 1997
- 55 Personal information in medical research
- 56 Use and disclosure of medical data – guidance on the Application of the Data Protection Act, 1998, May 2002
- 57 Guidelines for the ethical conduct of medical research involving children
- 58 Clinical investigation of medicinal products in the paediatric population
- 59 Guidelines for researchers and for ethics committees on psychiatric research involving human participants – executive summary
- 60 The ethical conduct of research on the mentally incapacitated
- 61 Volunteering for research into dementia Alzheimer's Society
- 62 Knowledge to care: research and development in hospice and specialist palliative care – executive summary
- 63 NUS guidelines for student participation in medical experiments and guidance for students considering participation in medical drug trials
- 64 Ethical considerations in HIV preventive vaccine research
- 65 2002 international ethical guidelines for biomedical research involving human subjects
- 66 1991 international guidelines for ethical review of epidemiological studies
- 67 Operational guidelines for ethics committees that review biomedical research
- 68 Registration of an institutional review board (IRB) or independent ethics committee (IEC)
- 69 International guidelines on bioethics (informal listing of selected international codes, declarations, guidelines etc. on medical ethics/bioethics/health care ethics/human rights aspects of health)
- Index
Summary
Recommended for Adoption at Step 4 of the ICH Process on 20 July 2000 by the ICH Steering Committee
This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA.
Clinical investigation of medicinal products in the pediatric population
ICH Harmonised Tripartite Guideline
Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 19 July 2000, this guideline is recommended for adoption to the three regulatory parties to ICH
Clinical investigation of medicinal products in the pediatric population
Introduction
Objectives of the guidance
number of medicinal products currently labeled for pediatric use is limited. It is the goal of this guidance to encourage and facilitate timely pediatric medicinal product development internationally. The guidance provides an outline of critical issues in pediatric drug development and approaches to the safe, efficient, and ethical study of medicinal products in the pediatric population.
Background
ICH documents with relevant information impacting on pediatric studies include:
E2: Clinical Safety Data Management
E3: Structure and Content of Clinical Study Reports
E4: Dose-Response Information to Support Drug Registration
E5: Ethnic Factors in the Acceptability of Foreign Clinical Data
E6: Good Clinical Practice: Consolidated Guideline
E8: General Considerations for Clinical Trials
E9: Statistical Principles for Clinical Trials
E10: Choice of Control Group in Clinical Trials
M3: Nonclinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals
Q1: Stability Testing
Q2: Validation of Analytical Procedures
Q3: Impurity Testing
- Type
- Chapter
- Information
- Manual for Research Ethics CommitteesCentre of Medical Law and Ethics, King's College London, pp. 420 - 428Publisher: Cambridge University PressPrint publication year: 2003
- 1
- Cited by